---
title: "ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292765683.md"
description: "After an illustrious career spanning four decades in health system leadership, including a remarkable 12-year tenure as Director General of Sheba Medical Center, Zeev Rotstein, M.D. has been appointed Chairman. Dr. Rotstein's vast experience and expertise bring invaluable insights to his new role."
datetime: "2026-07-15T12:02:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292765683.md)
  - [en](https://longbridge.com/en/news/292765683.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292765683.md)
generator: "portal-rs"
---

# ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform

After an illustrious career spanning four decades in health system leadership, including a remarkable 12-year tenure as Director General of Sheba Medical Center, Zeev Rotstein, M.D. has been appointed Chairman. Dr. Rotstein's vast experience and expertise bring invaluable insights to his new role.

### Related Stocks

- [FEED.US](https://longbridge.com/en/quote/FEED.US.md)

## Related News & Research

- [Silicon Valley wealth managers say elite tech workers are making these 5 money moves as AI mania continues](https://longbridge.com/en/news/297398623.md)
- [AI Was Supposed to Kill Wix. Google Just Gave It a Way to Fight Back.](https://longbridge.com/en/news/297433684.md)
- [Sandvik to host capital markets day for investors and analysts](https://longbridge.com/en/news/297775768.md)
- [The Bot Now Clicks Buy: Your AI Is About To Start Spending Your Money](https://longbridge.com/en/news/297424265.md)
- [Why Semtech (SMTC) Is Up 5.7% After Strong Q2 Results And AI-Focused Guidance – And What's Next](https://longbridge.com/en/news/297384085.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**